Article
29 Apr 2025
Celltrion Adalimumab Biosimilar Granted Interchangeability Designation
AUTHORS CONTENT
Article
11 Feb 2025
EU Biosimilar Regulatory And Launch Updates
Article
22 Nov 2024
Amgen Files BPCIA Complaint Against Accord Biopharma Regarding Denosumab Biosimilar
Article
11 Jul 2024
FDA Approves Ustekinumab, Aflibercept, And Filgrastim Biosimilars
Article
10 Jun 2024
Amgen Files BPCIA Complaint Against Celltrion Regarding Denosumab
Article
05 Jun 2024
Denosumab Biosimilar Updates
Article
22 Jan 2024
Alexion Sues Samsung Over Proposed Eculizumab Biosimilar
Article
16 Jan 2024
Goodwin Releases Update To Its Comprehensive Guide To Biosimilars Litigation And Regulation In The U.S.
Article
03 Nov 2023
FDA Approves LOQTORZI In All Lines Of Treatment For Recurrent Or Metastatic Nasopharyngeal Carcinoma
Article
28 Sep 2023
Scheduling Order Issued In REGENXBIO v. Sarepta Litigation